Adenovirus-mediated interferon-β gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice

International Journal of Oncology

Volumn 29, Issue 6, 2006, Pages 1405-1412

  Lee, Juwon ^a   Wang, Amy ^a   Hu, Qiande ^a   Lu, Shan ^a   Dong, Zhongyun ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Adenoviral vectors; Angiogenesis; Interferon ; Prostate cancer

Indexed keywords

BETA INTERFERON; INTERLEUKIN 8; MESSENGER RNA; VASCULOTROPIN A;

ADENOVIRUS; ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL GROWTH; DOWN REGULATION; DRUG SCREENING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PROSTATE TUMOR; VASCULARIZATION;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL GROWTH PROCESSES; DOWN-REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERFERON-BETA; INTERLEUKIN-8; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33847276456     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.6.1405     Document Type: Article

References (44)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005.
2. Steele GS and Richie JP: Management of local failure following treatment of localized prostate cancer. In: Advanced Therapy of Prostate Disease. Resnick MI and Thompson IM (eds). B.C. Decker Inc., Hamilton, Ontario, pp365-377, 2000.
3. Lokshin A, Mayotte JE and Levitt ML: Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines. J Natl Cancer Inst 87: 206-212, 1995.
4. Belhumeur P, Lanoix J, Blais Y, Forget D, Steyaert A and Skup D: Action of spontaneously produced beta interferon in differentiation of embryonal carcinoma cells through an autoinduction mechanism. Mol Cell Biol 13: 2846-2857, 1993.
5. Qin XQ, Runkel L, Deck C, De Dios C and Barsoum J: Interferon-beta induces S phase accumulation selectively in human transformed cells. J Interferon Cytokine Res 17: 355-367, 1997. (Pubitemid 27260291)
6. Clemens MJ: Interferons and apoptosis. J Interferon Cytokine Res 23: 277-292, 2003.
7. Biron CA: Interferons alpha and beta as immune regulators - a new look. Immunity 14: 661-664, 2001.
8. Albini A, Marchisone C, Del Grosso F, Benelli R, Masiello L, Tacchetti C, Bono M, Ferrantini M, Rozera C, Truini M, Belardelli F, Santi L and Noonan DM: Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: a gene therapy approach. Am J Pathol 156: 1381-1393, 2000.
9. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N and Fidler IJ: Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 92: 4562-4566, 1995.
10. Yamamoto S, Yasui W, Kitadai Y, Yokozaki H, Haruma K, Kajiyama G and Tahara E: Expression of vascular endothelial growth factor in human gastric carcinomas. Pathol Int 48: 499-506, 1998. (Pubitemid 28341085)
11. Einhorn S and Grander D: Why do so many cancer patients fail to respond to interferon therapy? J Interferon Cytokine Res 16: 275-281, 1996.
12. Ferrantini M and Belardelli F: Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications. Semin Cancer Biol 10: 145-157, 2000. (Pubitemid 30458474)
13. Alizadeh H, Howard K, Mellon J, Mayhew E, Rusciano D and Niederkorn JY: Reduction of liver metastasis of intraocular melanoma by interferon-beta gene transfer. Invest Ophthalmol Vis Sci 44: 3042-3051, 2003. (Pubitemid 36759771)
14. Odaka M, Sterman DH, Wiewrodt R, Zhang Y, Kiefer M, Amin KM, Gao GP, Wilson JM, Barsoum J, Kaiser LR and Albelda SM: Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity. Cancer Res 61: 6201-6212, 2001.
15. Kruklitis RJ, Singhal S, Delong P, Kapoor V, Sterman DH, Kaiser LR and Albelda SM: Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma. J Thorac Cardiovasc Surg 127: 123-130, 2004. (Pubitemid 38160475)
16. Kobayashi N, Kuramoto T, Chen S, Watanabe Y and Takakura Y: Therapeutic effect of intravenous interferon gene delivery with naked plasmid DNA in murine metastasis models. Mol Ther 6: 737-744, 2002. (Pubitemid 36054307)
17. Hendren SK, Prabakaran I, Buerk DG, Karakousis G, Feldman M, Spitz F, Menon C and Fraker DL: Interferon-beta gene therapy improves survival in an immunocompetent mouse model of carcinomatosis. Surgery 135: 427-436, 2004.
18. Streck CJ, Ng CY, Zhang Y, Zhou J, Nathwani AC and Davidoff AM: Interferon-mediated anti-angiogenic therapy for neuroblastoma. Cancer Lett 228: 163-170, 2005.
19. Streck CJ, Zhang Y, Miyamoto R, Zhou J, Ng CY, Nathwani AC and Davidoff AM: Restriction of neuroblastoma angiogenesis and growth by interferon-alpha/ beta. Surgery 136: 183-189, 2004. (Pubitemid 39037652)
20. Lu W, Fidler IJ and Dong Z: Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus-mediated interferon beta gene therapy. Cancer Res 59: 5202-5208, 1999. (Pubitemid 29503983)
21. Lu W, Su J, Kim LS, Bucana CD, Donawho C, He J, Fidler IJ and Dong Z: Active specific immunotherapy against occult brain metastasis. Cancer Res 63: 1345-1350, 2003. (Pubitemid 36348715)
22. Odaka M, Wiewrodt R, De Long P, Tanaka T, Zhang Y, Kaiser L and Albelda S: Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy. Mol Ther 6: 210-218, 2002. (Pubitemid 36336128)
23. Natsume A, Mizuno M, Ryuke Y and Yoshida J: Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse. Gene Ther 6: 1626-1633, 1999. (Pubitemid 29465522)
24. Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W, Bucana CD, Balbay MD, Bielenberg D and Fidler IJ: Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Cancer Res 59: 872-879, 1999.
25. Zhang F, Lu W and Dong Z: Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice. Clin Cancer Res 8: 2942-2451, 2002.
26. Cao G, Su J, Lu W, Zhang F, Marteralli D, Zhao G and Dong Z: Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice. Cancer Gene Ther 8: 497-505, 2001.
27. Constantinescu SN, Croze E, Wang C, Murti A, Basu L, Mullersman JE and Pfeffer LM: Role of interferon alpha/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha/beta receptor complex. Proc Natl Acad Sci USA 91: 9602-9606, 1994.
28. Keay S and Grossberg SE: Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes. Proc Natl Acad Sci USA 77: 4099-4103, 1980.
29. Graham FL and Prevec L: Manipulation of adenovirus vectors. In: Gene Transfer and Expression Protocols. Murray EJ (ed). Humana Press, NJ, pp109-128, 1991.
30. Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME and Hart IR: Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44: 3522-3529, 1984.
31. Stephenson RA, Dinney CP, Gohji K, Ordonez NG, Killion JJ and Fidler IJ: Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 84: 951-957, 1992.
32. Greene GF, Kitadai Y, Pettaway CA, von Eschenbach AC, Bucana CD and Fidler IJ: Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am J Pathol 150: 1571-1582, 1997.
33. Simon P: Q-gene: processing quantitative real-time RT-PCR data. Bioinformatics 19: 1439-1440, 2003.
34. Wilson GD, Camplejohn RS, Martindale CA, Brock A, Lane DP and Barnes DM: Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10. Eur J Cancer 12: 2010-2017, 1992.
35. Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 3: 65-71, 1992.
36. Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ and Dinney CP: Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Clin Cancer Res 5: 783-789, 1999.
37. Uehara H, Troncoso P, Johnston D, Bucana CD, Dinney C, Dong Z, Fidler IJ and Pettaway CA: Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage. Prostate 64: 40-49, 2005.
38. Murphy C, McGurk M, Pettigrew J, Santinelli A, Mazzucchelli R, Johnston PG, Montironi R and Waugh DJ: Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin Cancer Res 11: 4117-4127, 2005.
39. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP and Kreutzer DL: Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 51: 161-167, 1998.
40. Zhang F, Lee J, Lu S, Pettaway CA and Dong Z: Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Clin Cancer Res 11: 4512-4520, 2005.
41. Moore BB, Arenberg DA, Stoy K, Morgan T, Addison CL, Morris SB, Glass M, Wilke C, Xue YY, Sitterding S, Kunkel SL, Burdick MD and Strieter RM: Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol 154: 1503-1512, 1999.
42. Kitagawa Y, Dai J, Zhang J, Keller JM, Nor J, Yao Z and Keller ET: Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer Res 65: 10921-10929, 2005. (Pubitemid 41713360)
43. Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, Claffey K and Levine AC: Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis 17: 687-694, 1999. (Pubitemid 30450191)
44. Olson MV, Lee J, Zhang F, Wang A and Dong Z: Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy. Cancer Gene Ther 13: 676-685, 2006. (Pubitemid 44268951)